MDS Nordion brings third cyclotron on line

MDS Nordion Inc has officially launched its third cyclotron at TRIUMF on the campus of the Univ of British Columbia. The TR-30-2 cyclotron has begun commercial production of medical isotopes following authorization by the Canadian Nuclear Safety Commission. The $20-million project, which includes an expansion of the site’s production facility and new development space, will help to meet the surging demand for isotopes for medical diagnostic and therapeutic applications. Its particular focus will be on production of isotopes used in the diagnosis and management of thyroid cancer and assessment of thyroid function. MDS Nordion is a division of MDS Inc and the world’s leading supplier of medical isotopes….